Leerink Swann Starts OncoGenex Pharmaceuticals (OGXI) at Outperform; Evolution of Drug Development

Go back to Leerink Swann Starts OncoGenex Pharmaceuticals (OGXI) at Outperform; Evolution of Drug Development